Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase EARLY_PHASE1 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Neoplasms 5Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Multiple Myeloma 3Lymphoma 3Uterine Cervical Neoplasms 2Sarcoma 2Neoplasms, Plasma Cell 2Lung Neoplasms 2Hodgkin Disease 2Glioblastoma 2Carcinoma, Renal Cell 2Vulvar Neoplasms 1Uterine Cervical Dysplasia 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma, Kaposi 1Prostate Cancer Recurrent 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Nelfinavir × Clear all
NCT01086332 2018-11-13

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

University of Iowa

Phase 1 Terminated
7 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT03422874 2018-02-06

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Dartmouth-Hitchcock Medical Center

Phase 1 Withdrawn
Lymphoid

Lymphoma, Neoplasms

NCT02080416 2016-06-10

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Terminated
1 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Castleman Disease, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Neoplasms, Sarcoma, Sarcoma, Kaposi, Stomach Neoplasms

NCT01485731 2015-06-03

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

University of Miami

Phase 1 Completed
8 enrolled
Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Neoplasms

NCT01079286 2013-07-15

I-NET

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1 Completed
18 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡